Hello Kenneth and Welcome, Sure looks like you could play it that way doesn't it? I really don't know what to say about it lately. I'm as confused as the next guy. If you read through the posts on the thread, you will see trial results with efficacies surpassing about any biotech offering out there. I own IDEC and I will continue to own it because sooner or later, the market is going to reward this company.
My guess is that IDEC, having fallen sometimes with speed as blinding as it has risen with, has given alot of its loyal holders a hair-trigger. If it starts to sell-off, all the loyal holders get the heck out. If it starts to recover, all the loyal holders are back in PRONTO. Sounds silly but I bet there's some truth to it. Only way I can explain the speed. I have been following it and noticing it for so long that, I'm sure others will attest, I can call those turn-arounds to the day :o).
Seriously, it is the most promising biotech I know of. Volatile as heck so, if you're in, you're in for a ride but, with FDA approval coming up for their NHL therapy and an INCREDIBLE (and that's not hype) arthritis treatment in phase III, I think this is about as good as it gets plus or minus a few bucks.
have a good evening,
BENNETT |
